Financhill
Back

Zions Bancorp NA Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
50

ZION
Zions Bancorp NA

Last Price:
$42.01
Seasonality Move:
3.19%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
$51.00
Seasonality Move:
12.51%
Sell
50
Zions Bancorp NA (ZION) is a Sell

Is Zions Bancorp NA a Buy, Sell or Hold?

  • The current Zions Bancorp NA [ZION] share price is $42.47. The Score for ZION is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ZION is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $50.31. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ZION Stock Price Chart

What is Zions Bancorp NA's stock price today?

  • The Zions Bancorp NA share price today is $42.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZION is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $50.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ZION Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.32 Sell
Relative Strength Index (14 RSI): 35.51 Sell
Chaikin Money Flow: -696340 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.91 - 50.87) Sell
Bollinger Bands (100): (49.91 - 59.23) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.43 Sell
Relative Strength Index (14 RSI): 25.41 Sell
Chaikin Money Flow: -2337291 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.24 - 93.24) Sell
Bollinger Bands (100): (85.21 - 128.11) Sell

ZION Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.77 Sell
20-day SMA: 47.73 Sell
50-day SMA: 51.71 Sell
200-day SMA: 51.34 Sell
8-day EMA: 44.67 Sell
20-day EMA: 47.11 Sell
50-day EMA: 50.3 Sell
200-day EMA: 50.58 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.64 Sell
20-day SMA: 68.68 Sell
50-day SMA: 92.51 Sell
200-day SMA: 121.01 Sell
8-day EMA: 56.28 Sell
20-day EMA: 67.87 Sell
50-day EMA: 86.24 Sell
200-day EMA: 111.03 Sell

Zions Bancorp NA Earnings Growth & ZION Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.39 per share, and an increase next year of $0.41 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.35 per share, a decrease next quarter of $0.47 per share, an increase this year of $4.58 per share, and an increase next year of $5.49 per share.

Zions Bancorp NA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):